High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: A Single Institution Experience at All India Institute of Medical Sciences, New Delhi, Using Non-Cryopreserved Peripheral Blood Stem Cells-Reference-Cited by-同舟云学术

High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: A Single Institution Experience at All India Institute of Medical Sciences, New Delhi, Using Non-Cryopreserved Peripheral Blood Stem Cells

Published:2014-04 Issue:2 Volume:14 Page:140-147
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kayal Smita,Sharma Atul,Iqbal Sobuhi,Tejomurtula Tilak,Cyriac Sunu L.,Raina Vinod

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference44 articles.

1. Hematopoietic stem cell transplantation: a global perspective;Gratwohl;JAMA,2010

2. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome;Attal;N Engl J Med,1996

4. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe;Fermand;J Clin Oncol,2005

5. High-dose therapy autotransplantation/intensification vs continued standard chemotherapy in multiple myeloma in first remission. Results of a non-randomized study from a single institution;Bladé;Bone Marrow Transplant,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost of multiple myeloma and its complications: A single-center study from Oran, Algeria;Annales Pharmaceutiques Françaises;2024-06

2. Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings;Cureus;2023-03-24

3. Outpatient Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

4. An Update on Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

5. Outcome of Outpatient Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma and Relapsed and Refractory Hodgkin Lymphoma. The Experience of King Fahad Specialist Hospital in Dammam, Saudi Arabia;Journal of Stem Cell Therapy and Transplantation;2023-03-08